Iambic Therapeutics sets IPO at $15-$17 per share
Iambic Therapeutics plans to sell nearly 9.4 million shares in its IPO at $15-$17 each, targeting about $135 million in net proceeds at the $16 midpoint.
Iambic Therapeutics plans to sell nearly 9.4 million shares in its IPO at $15-$17 each, targeting about $135 million in net proceeds at the $16 midpoint.